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75% in the no-treatment arm (p=0.04). (2) Secondary end points: Death st one week was 
23% in the L-NMMA arm vs. 75% in the no-treatment arm (p=0.01). Unaugrnented mean 
arterial blood pressure (MAP) at 24 hours was 80±17 mmHg in the L-NMMA arm vs. 
66±13 mmHg in the no-treatment arm (p=0.04). MAP increased by 20±17 mmHg vs 
2.5±10 mmHg respectively (p=0.005). Udne output at 24 hours was 223±88 cc/hour in 
the L-NMMA arm vs 119±93 cc/hour in the no-treatment arm (p=0.Ol). Udne output 
increased by 141±81 cc/hour in the L-NMMA arm vs -11±93 cc/hour in the no treatment 
arm (p=0.001). Time on IABP was 59±58 hours in the L-NMMA arm vs. 90±56 hours in 
the no treatment arm (p=0.15). "[]me on mechanical ventilation was 73±51 hours and 
121 ±53 hours respectively (p=0.03). 
Conclusion: From these preliminary results it seems that L-NMMA is beneficial in the 
treatment of patients in refractory cardiogenic shock. 
3:15 p.m. 
862-6 E lec t rocard iograph ic  Lef t  Vent r i cu la r  Hyper t rophy  Is 
Associated With Mortality and Left  Vent r i cu la r  Rupture 
in Patients With Acute Myocardial Infarction 
David S. Marks, Surendra B. Gudapati, James F. Kleczka, Sabina A. Murphy, 
Christopher P. Cannon, Eugene Braunwald, C. M, Gibson, Medical College of Wisconsin, 
Milwaukee, Wisconsin, Harvard Medical School, Boston, Massachusetts. 
Background: Left ventricular hypertrophy (LVH) is a potent predictor of cardiovascular 
events, particularly in the presence of coronary artery disease. The impact of LVH in 
patients with acute myocardial infarction is incompletely understood. 
Methods: The data sets of TIMI lOB and TIM114 were pooled. Electrocardiograms were 
classified as LVH present (n=191), LVH absent (n=1,250), or uninterpretable (n=91). Mul- 
tivariate analysis was performed to examine 30 day mortality, TIMI flow, and cause of 
death. 
Results: Patients with electrocardiographic LVH compared to LVH absent were older 
(60.5 vs 58.3 years; p=0.01), black race (13.4 vs 4.1%; p<O.O01), and experienced an 
anterior MI (42.2 vs 33.7%). Death (6.25 vs 3.1%; p=0.029) and the composite death/MI/ 
failure/shock (12.5 vs 8.1%; p=0.04) were increased in the LVH group, Angiogrephic 
characteristics including TIMI flow did not differ between groups. The LVH group died fre- 
quently from ventricular rupture compared to LVH absent (33.3 vs 7.8%; p=0.04). 
Patients with uninterpretable lectrocardiograms had the highest mortality (9.9%) with no 
increase in ventricular upture (11.1%). 
Conclusions: In patients treated with lytic reperfusion therapy, the presence of electro. 
cardiographic LVH portends a significantly worse outcome, independent of coronary 
blood flow. Moreover, these patients died more frequently from ventricular upture com- 
pared to patients without LVH. Further investigation is required to determine the mecha- 
nism of increased mortality and the increased incidence of ventdcular rupture. 
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1192-31 An Intramyocardial Imp lant  Sys tem Su i tab le  for 
Susta ined-Re lease  Del ivery  to Ischemic Myocardium 
Takafumi Ueno. Keith A. Robinson, Jianhua Cui, Jennifer J. Fitzgerald, David M. 
Hoganson, John E. Nash, Nicolas Chronce, Atlanta Cardiovascular Research Institute, 
Norcross, Georgia, Kensey Nash Coporation, Exton, Pennsylvania. 
Background: Current techniques for local treatment of diseased myocardium with drugs 
or genes do not allow sustained retease. A bioabsorbable polymer implant system was 
tested for local tissue reaction and potential utility to deliver therapeutic agents. Meth- 
ods: Normal juvenile pigs (n=3); and juvenile (n=13) and adult Yucatan (n=12) pigs with 
chronic myocardial ischemia induced by coronary amereid constriction received braided 
polylactide/polyglycotide implants (average 12 implants) or sham therapy by direct injec- 
tion implantation into the left ventdcular free wall via thoracotomy. Responses to implant 
and sham injections were evaluated by dobutamine stress echocerdiography (DSE), cor- 
onary angiography, micrcephere-based blood flow measurement, histology, and histo- 
morphometry. Results: Implantation was readily achieved without significant bleeding 
using the prototype system. Absorption of implants was nearly complete by 3 rod, via 
histiolymphocytic and fibrotic reaction accompanied by local neovascularization. In the 
amereid study, 3 pigs died after amereid placement, 2 after baseline DSE, and 2 after 
intramyocardial injection procedures. There were no differences between sham-injected 
or implanted pigs (juvenile at 1 mo, or Yucatan at 3 rod) in regional wall motion scores on 
DSE, % stenosis or collateral scores by angiography, or in myocardial blood flow at rest 
or cardiac pacing. However, pigs receiving implants in the ischemic zone had increased 
capillary density compared to those receiving sham injection in epicardial (597+103 vs 
460+167/mm 2, P=0.05) and tendency in endocardial (675+183 vs 489+210/mm 2,
P=0.06) regions. Curiously, this effect also involved the adjacent non-ischemic non- 
injected myccardium (586+138 vs 403+164/mm 2, P=0.02 in epicardium; 617+188 vs 
427+222/mm 2, trend at P=O.08 for endocardium). Conclusions: A novel intramyocardial 
absorbable implant does not impair cardiac function after implant in chronically ischemic 
tissue, and is associated with increased angiogenesis. This system may be useful for 
localized sustained-release delivery of conventional drugs or gene-based molecular ther- 
apies in treatment of chronic myocardial ischemia. 
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1192-32 Increas ing  Left  Vent r i cu la r  Spher ic i ty  Is Associated 
With Decreased  Surv iva l  Even  in Pat ients  With TIMI-3 
Flow or Inferior Infarction 
Selwvn P. Wono, John K. French, Wanzhen Gad, Harvey D. White, Green Lane Hospital, 
Auckland, NewZealand. 
Background: Following acute myocardial infarction (MI), left ventdcu~ar (LV) function and 
volumes are closely associated with late survival, though there is little data on the rela- 
tionship between LV sphericity and late survival Method & Results: To examine the asso- 
ciation between late survival and LV sphericity, assessed on biplane contrast 
ventriculogrephy at 3 weeks, we studied 767 patients presenting with electrocardio- 
graphic ST-segment elevation within 4 hours of symptom-onset who were enrolled in 3 
trials of thrombolytic and adjunctive therapies. When both ventricular volumes and 
regional wall motion were normal, median biplane LV sphericity index was 0.56 (inter- 
quartile range 0.51-0.60), determined as the average ratio of the short to long axes in the 
right and left anterior oblique projections. Decreased survival was associated with 
increasing LV sphericity even in patients with TIMI 3 flow or inferior infarction (Fig). inde- 
pendent multivariate predictors of decreased 10 year survival were lower ejection fraction 
(P=O.002), decreased treadmill exercise duration (P=0.04), increasing sphericity index 
(P=0.032), increased age (P=0.043), and increased end-systolic volume index (P=0.047) 
but not TIMI flow grade or infarct-related artery. Conclusion. The simple biplane LV sphe- 
ricify index of the ratios of the minor to major axis predicts late survival in patients with 
TIM1 3 flow or inferior MI. 
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1192-33 Thrombo ly t i c  F ibr in  Spec i f i c i ty  In f luences  Act ivated  
Partial Thromboplastln Time Prolongation 
James p, Tsikouds, Kenneth C. Jackson, II, Craig D. Cox, Gary E. Msyerrese, Jose A. 
Diaz, Chades F. Seifert, Texas Tech University Health Science Center, Lubbock, Texas. 
Despite limited clinical trial evidence, current guidelines suggest the same unfractionated 
hepadn (UFH) dosing for all fibrin specific thrombolytic agents used for acute myocardial 
infarction (AMI). Since excessive aPTT prolongation correlates with bleeding and mortal- 
ity, clarifying the effects of various fibrin specific agents on the aP'l-r is needed. Alteplase 
(rt-PA) is slightly more fibrin specific than reteplase (r-PA), and tenecteplase (TNK) is 
exceedingly more fibrin specific than rt-PA and r-PA. Methods: We treated blood samples 
from healthy volunteers (n=12) with equipotent concentrations of rt-PA (4 mcg/ml), r-PA 
(4.2 mcg/rnl), or TNK (8.6 mcg/ml), with and without UFH (0.3 U/ml). Each treatment 
group samples - rt.PA alone, r-PA alone, TNK alone, UFH, UFH + rt.PA, UFH + r-PA, 
UFH + TNK - were incubated at simulated body temperature, with aPTT and fibrinogen 
measured after 4 hours. Data were analyzed using repeated measures ANOVA with 
Bonferreni t-test and Pearson correlation. Mean aPTT values for rt-PA alone and r-PA 
alone were significantly prolonged compared to TNK alone, which were in the normal 
range for 11 of 12 patients (85 vs. 62 vs. 32 secs, respectively, p=0.001 for both), rt-PA 
alone prolonged the aPTT to a greater extent than r-PA alone (p<0.02). Combined with 
UFH, rt-PA end r-PA significantly increased the aPTT vs. UFH alone (234 and 228 vs. 
187 secs, p<0.02 for both). Interestingly, UFH + TNK significantly reduced the aP'l-r vs. 
UFH alone (137 vs. 187 secs, respectively, p<0.001). This finding was consistent for all 
12 patients. A significant correlation existed between decreasing fibrinogen and increas- 
ing aPT1" for all treatments (p<0.05), except TNK alone, which minimally reduced fibrino- 
gen vs. UFH alone. This relative comparison shows that an agent with maximal fibrin 
specificity (TNK) is unlikely to prolong the aP'l-r, while less fibrin specific agents have a 
greater propensity to prolong the aPTT with and without UFH. Also, TNK attenuates the 
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action of UFH in vitro. In light of these results, a reevaluation of UFH dosing in combina- 
tion with each individual fibrin specific thrombolytic agent used for AMI is warranted in the 
clinical setting. 
1192-34 Grat ing  o f  Three-d imens iona l  Co l lagen  Type 1 Sca f fo ld  
on Injured Myocardium Induces Neovascularizatlon and 
Improves Cardiac Function 
Mohamed A. Gaballa, Joseph Bahl, Eugene Morkin, Steven Goldman, University of 
Arizona, Tucson, Arizona, SAVAHCS, Tucson, Arizona. 
Grating cells into cardiac muscle has been proposed used as a potential mechanism for 
augmenting cardtomyocyte numbers in the adult heart. The fate and effect of engrafting 
fetal cells into infarcted hearts remains unclear. One approach to overcoming this limita- 
tion is to graft a naturally modified extrecellular matrix (collagen-1) scaffold onto the myo- 
cardium. We found, three-weeks after grafting, the 3-D collagen scaffold was integrated 
completely with the cryo-injured myocardium. The scaffold prevented LV dilation. At zero 
left ventricular (LV) pressure, the LV lumen diameter and the outer diameter measured at 
the equator were decreased from 11041±212 to 9144_+135 mm, and 13469 ±187 to 
11673 ±104, N=4, respectively). The scaffold improved cardiac function by shifting of the 
LV pressure-volume curve to the left toward control. It induced neoangiogeneeis with the 
graft (10 neovessel per 40x field versus zero), with the new vessels connected to native 
coronary vasculature in the noninfarcted myocardium. In addition, this neovascularization 
was associated with recruitment of endothelial progenitor stem cells, CD34 +. When com- 
pared to the infarcted rats, hemodynamics parameters measured at 3-wks after scaffold 
grafting were not different. Thus, this study shows that grafting 3-D collagen-1 scaffold 
onto an injured myocardium integrates with the tissue, allows for cell growth and differen- 
tiation, induces mature vessel formation within the graft, and results in improved cardiac 
diastolic function by preventing LV dilation. 
1192-35 80-Lead Body Map Detects Acute ST Elevation 
Myocardial Infarction Missed by Standard 12-Lead 
Electrocardiography 
Joseoh P. Ornato, lan B. Menown, John W. Riddell, Simon Carley, Kevin Mackway- 
Jones, George L. Higgins, ill, Mary Ann Peberdy, Michael C. Kontos, Suzanne J. 
Maynard, A.A. Jennifer Adgey, for the PRIME Investigators, Virginia Commonwea/th 
Universi~ Richmond, Virginia. 
Background: We conducted a multicanter clinical trial to determine whether an 80-1eed 
PRIME-ECG body map system (PRIME) could detect more acute ST-segment elevation 
MIs (STEMI) than standard 12-lead ECGs (ECG) in chest pain patients presenting to 4 
hospital EDs (Virginia Commonwealth University, Richmond, VA; Manchester Royal Infir- 
mary, Manchester, England; Maine Medical Center, Portland, ME; Royal Victoria Hospi- 
tal, Belfast, Northern Ireland). 
Methods: A trained technician performed an ECG and PRIME on all consenting adult ED 
chest pain patients in whom MI or ischemia was considered clinically. Sensitivity and 
specificity of each test for detecting STEMI was calculated using 3 different MI defini- 
tions, all of which required diagnostic ST elevation on either ECG or PRIME plus: 1) ele- 
vated CKMB (CKMB-MI); 2) elevated troponin (TROP-MI); or 3) a clinical discharge 
diagnosis of acute MI (CLIN-MI). 
Results (Table): 
The MI locations most commonly missed by ECG but detected by PRIME were: 1) 
CKMB-MI: 1 septal, 4 posterior (1 infero-post), 1 inferior; 2) CLIN-MI: 1 septal, 8 posterior 
(3 infero-post), 1 inferior; and 3) TROP-MI: 2 septal, 9 posterior (3 infero-post), 1 inferior. 
The incidence of extensive right ventricular involvement diagnosable only by PRIME in 
inferior STEMI was: CKMB-MI 2/9 (22%), TROP-MI 2/9 (22%), CLIN-MI 6/18 (33%). 
Conclusions: 
PRIME is more sensitive for detecting STEMI than ECG, but has similar specificity. Pos- 
terior MIs are most commonly missed by ECG but detected by PRIME. 
N ECG PRIME p ECG PRIME p 
sensitivity sensitivity specificity specificity 
CKMB-MI 22/365 72.7% 100% .02 97.1% 96.5% ns 
TROP-MI 28/225 57.1% 92.9% .008 96.5% 94.9% ns 
CLIN-MI 41/647 75.6% 90.2% .09 98.0% 96.7% ns 
1192-36 Rest Myocardial Perfusion Imaging Results in Patients 
With Troponin I Elevations 
Michael C. Kontos. Melvin J. Fratkin, Robed L Jesse, Joseph P. Ornato, James L. 
Tatum, MCV/VCU, Richmond, Virginia. 
Background: Myocardial perfusion imaging (MPI) is used often to identify patients (pts) 
with myocardial infarction (MI). Its diagnostic accuracy in pts with smaller amounts of 
damage as assessed by troponin, has not been well studied. Methods: Pts considered 
low risk for MI underwent rest gated tomographic MPI and serial marker assessment 
(CK, CK-MB and Tnl) as part of standard chest pain evaluation protocol. Pts with Tnl ele- 
vations were analyzed further for this study. MI was defined as CK-MB>8 ng/mL. MPI 
was considered positive if there was a perfusion defect in association with abnormal wall 
motion or thickening. Short axis images were divided into 17 segments and graded on a 
4 point scale (0 normal, 3 high grade or absent perfusion) and a summed defect score 
(SDS) was derived. Results: A total of 214 pts had MPI and Tnl elevations, of whom 93 
(39%) did not meet CK-MB MI criteria. MPI was positive in 181 (75%) including 63% of 
Tnl positive but CK-MB MI negative pts. Pts with positive MPI had a mean 2.6-+1.3 seg- 
ments abnormal and a mean SDS of 6.1±3.7. Pts with negative MPI had smaller MIs 
(peak CK-MB 18.-:23 vs 43±66 ng/mL, p<0.001), and were more likely to have non-signif- 
icant coronary disease on angiography (37% vs 17%, p<0.05) than those with positive 
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MPI. Higher SDS was associated with larger MIs as estimated by peak CK-MB and CK 
(Table). Conclusions: MPI and Tnl offer complementary data for assessing pts with pos- 
sible MI. Pts with ne~iative MPI have small MIs and less extensive coronary disease. 
SOS 0 1-3 4-6 7-9 > 10 
% In Each Group 25 17 26 14 11 
Median Peak CK-MB, ng/ml 7.2 16 20 31 43 
Median Peak CK, U/L 186 263 383 383 572 
11 92-37 Infarct Size Limitation by Gene Transfer of Baculoviral 
P35 Into Rat Myocardlum 
Lorenz Bott-Flueoel. Karl-Ludwig Laugwitz, Melchior Seyfarth, Chdstiane Faltermeier, 
Christine Baumgartner, Alessandre Moretti, Albert Schoemig, Deutsches Herzzentrum, 
Muenchen, Germany,/. Meal. K/inik, Klinikum Rechfs der Isar, Muenchen, Germany, 
Background: Apoptosis plays a pivotal role in determining the extent of injury during 
myocardial infarction. Inhibition of apoptosis has been shown to protect myocardium from 
damage during ischemia and reperfusion. The aim of this study was to determine 
whether gene transfer of baculoviral protein p35, a potent inhibitor of apoptosis, into myo- 
cardium could limit infarct size. Methods: Male Wistar rats were directly injected into the 
left antedor walt with adenoviral vector encoding baculoviral p35. 72 hours later hearts 
were mounted on a Langendorff apparatus and perfused. The left antedor descending 
coronary artery was ligatad for 30 minutes and reperfused for 2 hours. Area at risk and 
infarct size were determined by staining with bromophenolblue and triphenoltetrezolium- 
chloride ('I-I'C), respectively. Apoptosis was measured by assessing the DNA-laddering, 
and by in-situ staining for DNA-strand breaks (TUNEL-assay) and active caspass-3. 
Results: Infarct size was significantly reduced in animals treated with p35 (59 +/- 3 % 
reduction, p<0.05), whereas no reduction was seen when only control vector was 
injected. Apoptosis was diminished significantly only in animals treated with p35. Con- 
clusion: Gece transfer of the baculovirel protein p35 into the left vantricular myocardium 
diminishes caspase-3 activity and thereby reduces infarct size after regional ischemia 
and reperfusion. 
POSTER SESSION 
1193 Systemic Markers and Acute Coronary 
Syndromes 
Tuesday, March 19, 2002, 3:00 p.m.-5:00 p.m. 
Georgia World Congress Center, Hall G 
Presentation Hour: 4:00 p.m.-5:00 p.m. 
1193-27 Comparat ive  Analyses of the Prognostic Value of Novel 
Cardiac Markers In Patients With Non-ST Elevation 
Acute Coronary Syndromes 
Oscar Bazzino. Jos~ L. Navarro Estrada, Femando Botto, Maria I. Sosa Liprandi, Juan J. 
Fuselli, Jos~ Santopinto, Rodolfo Ahuad, Roberto Norclaby, Simdn Saiszberg, Alfredo 
Hirschson Prado, Jos~ Gant Lbpez, Mario Russo, Fernando Sokn, Mamelo P(~rez, 
Cados Bruno, PACS /nvestigators, Buenos Aires, A~entina. 
Background: Cardiac markers have different release characteristics, sensitivity and spec- 
ificity. A multi-marker strategy testing for prognostic markers may improve risk stratifica- 
tion in patients (pts) with non-ST-elevation acute coronary syndromes (NSTACS) 
Methods: This prospective multicanter cohort study included 1000 consecutive pts admit- 
ted with NSTACS. Baseline clinical and electrocardiographic data were recorded. Single 
assays of 3rd generation troponin T(TnT), high sensitivity C-reactive protein (CRP) and 
myoglobin (Myo), were performed after 9 hours (median) from symptom onset. Results 
were kept blinded until the end of the study. The association between markers and 180 
day events was examined by chi-squara and logistic regression analyses. The primary 
endpoint was the 180-day incidence of death or myocardial infarction (D/AMI). Results: 
D/AMI occurred in 9.4% of pts at 180 days. Prognostic values of total CK (upper normal 
value x2),TnT (>0.01ng/ml), CRP (>3 mg/I)and Myo (>80 ng/ml),were: 
180 day D/AMI 
n ER(%) OR 95%CI S Sp PPV NPV 
CRP>0.3 mg/I 602 12.0 2.2 1.3-3.6 75.7 41.4 12.0 94.2 
TnT>0.01 ng/ml 428 15.2 3.2 2.0-5.0 68.4 59.9 15.2 94.8 
Myo>80 ng/ml 243 18.9 3.3 2.2-5.2 48.4 78.2 18.9 93.5 
Total CK x 2 138 20.3 3.0 t .8-5.9 29.5 87.8 20.3 92.2 
ER: Event Rate, S: sensitivity, Sp: specificity, PPV: positive predictive value, NPV: neg- 
ative predictive value, OR: odds ratio 
By regression analyses, total CK was not an independent predictor. The TnT-only model 
significantly improved by adding Myo and CRP data (delta chi-square:20.03, p=0.006). 
Conclusions: In a non selected population of NSTACS, a model including 4 cardiac 
markers showed that TnT, Myo and CRP are independent predictors of adverse out- 
come. Total CK has not additional prognostic value on top of TnT, Myo and CRP.A combi- 
nation of these markers may assist to identify the pts at increased risk of future events. 
